https://ir.pelthos.com/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/_75f87c490a70454dbc03829ddee17a08/chromocell/files/theme/images/logo-sm.png Equisolve Investor Relations Suite https://ir.pelthos.com/news-events/press-releases/detail/55/pelthos-therapeutics-announces-cfo-transition Fri, 10 Apr 26 17:00:00 -0400 https://ir.pelthos.com/news-events/press-releases/detail/55/pelthos-therapeutics-announces-cfo-transition https://ir.pelthos.com/news-events/press-releases/detail/54/pelthos-therapeutics-announces-first-patient-dosed-in-phase-1b2a-clinical-trial-of-ct2000-in-eye-pain Tue, 31 Mar 26 08:30:00 -0400 https://ir.pelthos.com/news-events/press-releases/detail/54/pelthos-therapeutics-announces-first-patient-dosed-in-phase-1b2a-clinical-trial-of-ct2000-in-eye-pain https://ir.pelthos.com/news-events/press-releases/detail/53/pelthos-therapeutics-announces-fourth-quarter-and-full-year-2025-financial-results Thu, 19 Mar 26 06:30:00 -0400 https://ir.pelthos.com/news-events/press-releases/detail/53/pelthos-therapeutics-announces-fourth-quarter-and-full-year-2025-financial-results https://ir.pelthos.com/news-events/press-releases/detail/52/pelthos-therapeutics-to-present-at-38th-annual-roth-conference Thu, 12 Mar 26 08:30:00 -0400 https://ir.pelthos.com/news-events/press-releases/detail/52/pelthos-therapeutics-to-present-at-38th-annual-roth-conference https://ir.pelthos.com/news-events/press-releases/detail/51/pelthos-therapeutics-to-report-fourth-quarter-and-full-year-2025-financial-results-on-march-19-2026 Mon, 09 Mar 26 08:30:00 -0400 https://ir.pelthos.com/news-events/press-releases/detail/51/pelthos-therapeutics-to-report-fourth-quarter-and-full-year-2025-financial-results-on-march-19-2026 https://ir.pelthos.com/news-events/press-releases/detail/50/pelthos-therapeutics-to-present-at-the-oppenheimer-36th-annual-healthcare-life-sciences-conference Mon, 23 Feb 26 08:00:00 -0500 https://ir.pelthos.com/news-events/press-releases/detail/50/pelthos-therapeutics-to-present-at-the-oppenheimer-36th-annual-healthcare-life-sciences-conference https://ir.pelthos.com/news-events/press-releases/detail/49/pelthos-therapeutics-secures-up-to-50-million-senior-secured-term-loan-facility-from-horizon-technology-finance Tue, 13 Jan 26 08:30:00 -0500 https://ir.pelthos.com/news-events/press-releases/detail/49/pelthos-therapeutics-secures-up-to-50-million-senior-secured-term-loan-facility-from-horizon-technology-finance https://ir.pelthos.com/news-events/press-releases/detail/48/pelthos-therapeutics-acquires-xeglyze-abametapir-topical-treatment-for-head-lice Mon, 05 Jan 26 07:30:00 -0500 https://ir.pelthos.com/news-events/press-releases/detail/48/pelthos-therapeutics-acquires-xeglyze-abametapir-topical-treatment-for-head-lice https://ir.pelthos.com/news-events/press-releases/detail/47/pelthos-therapeutics-expands-board-of-directors-with-the-appointment-of-andrew-einhorn Tue, 23 Dec 25 17:57:00 -0500 https://ir.pelthos.com/news-events/press-releases/detail/47/pelthos-therapeutics-expands-board-of-directors-with-the-appointment-of-andrew-einhorn https://ir.pelthos.com/news-events/press-releases/detail/46/pelthos-therapeutics-signs-major-pharmacy-benefit-manager-agreement-expanding-patient-access-to-zelsuvmi-berdazimer-topical-gel-10-3 Thu, 04 Dec 25 07:00:00 -0500 https://ir.pelthos.com/news-events/press-releases/detail/46/pelthos-therapeutics-signs-major-pharmacy-benefit-manager-agreement-expanding-patient-access-to-zelsuvmi-berdazimer-topical-gel-10-3